Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Delila J. Kern
GA101 Induces NK-cell Activation and Antibody-Dependent Cellular Cytotoxicity More Effectively Than Rituximab When Complement Is Present
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Related publications
A Novel Anti‑EGFR Monoclonal Antibody (EMab‑17) Exerts Antitumor Activity Against Oral Squamous Cell Carcinomas via Antibody‑dependent Cellular Cytotoxicity and Complement‑dependent Cytotoxicity
Oncology Letters
Cancer Research
Oncology
Enhancement of Antibody-Dependent Cell-Mediated Cytotoxicity of Herpesvirus-Infected Cells by Complement.
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Canine Non-B, Non-T NK Lymphocytes Have a Potential Antibody-Dependent Cellular Cytotoxicity Function Against Antibody-Coated Tumor Cells
BMC Veterinary Research
Medicine
Veterinary
Erratum To: NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Is Enhanced by Tamoxifen in HER2/neu Non-Amplified, but Not HER2/neu-amplified, Breast Cancer Cells
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Mutations of Recombinant Aquaporin-4 Antibody in the Fc Domain Can Impair Complement-Dependent Cellular Cytotoxicity and Transplacental Transport
Frontiers in Immunology
Allergy
Immunology
Influenza a Virus Antibodies With Antibody-Dependent Cellular Cytotoxicity Function
Viruses
Virology
Infectious Diseases
Designing Immunity to HIV: Manipulating Antibody-Dependent Cellular Cytotoxicity Antibodies
HIV Therapy
Cholesterol Crystal-Induced Endothelial Cell Activation Is Complement-Dependent and Mediated by TNF
Immunobiology
Allergy
Immunology
Hematology
Systemic Interleukin-2 and Adoptive Transfer of Lymphokine-Activated Killer Cells Improves Antibody-Dependent Cellular Cytotoxicity in Patients With Relapsed B-Cell Lymphoma Treated With Rituximab
Clinical Cancer Research
Cancer Research
Oncology
